AOTI, Inc. Expands Medicaid Coverage and Strengthens Market Position

AOTI, Inc. ( (GB:AOTI) ) just unveiled an announcement.

AOTI, Inc. has announced a significant expansion in its Medicaid coverage, now billing in all six states outlined at its IPO and achieving a combined Medicaid run rate of approximately $2.3 million by December 2024. The company is experiencing strong trading momentum, attributed to its strategic focus on higher value market segments beyond the Veterans Administration. This expansion is supported by increasing payer recognition of the TWO2® therapy benefits, contributing to AOTI’s confidence in its growth prospects for FY2025.

More about AOTI, Inc.

AOTI, Inc. is a medical technology company founded in 2006 with operations in Oceanside, California, and Galway, Ireland. It specializes in innovative solutions for the treatment of severe and chronic wounds, particularly through its patented Topical Wound Oxygen (TWO2®) therapy. The company’s products aim to reduce healthcare costs and improve patient quality of life, with regulatory approvals across various global markets.

YTD Price Performance: 8.11%

Average Trading Volume: 78,168

Technical Sentiment Consensus Rating: Strong Buy

Current Market Cap: £127.6M

For detailed information about AOTI stock, go to TipRanks’ Stock Analysis page.